Kruk Mariusz, Przyłuski Jakub, Kalińczuk Łukasz, Pregowski Jerzy, Deptuch Tomasz, Kadziela Jacek, Bekta Paweł, Karcz Maciej, Demkow Marcin, Chmielak Zbigniew, Witkowski Adam, Ruzyłło Witold
Cathetherization Laboratory and Coronary Disease Unit, National Institute of Cardiology, Warsaw, Poland.
Circ J. 2008 Feb;72(2):205-11. doi: 10.1253/circj.72.205.
The association of inflammatory markers with mortality in ST-elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention (PCI) remains controversial, so in the present study the relationships of high-sensitivity C-reactive protein (hs-CRP), total white blood cell (WBC) count, neutrophil (N) and lymphocyte (L) counts and the N/L ratio with occurrence of in-hospital mortality were assessed in patients with STEMI treated with primary PCI.
Inflammatory parameters were assessed on admission in 1,078 consecutive, unselected patients with STEMI admitted for primary PCI. In-hospital death occurred in 6.3% of the patients. Of the inflammatory parameters, only hs-CRP (p<0.001), and the WBC (p=0.004) and N (p=0.020) counts were predictors of death in the univariate analyses. After adjustment for other baseline clinical variables both hs-CRP and WBC count retained their independent association with mortality when analyzed both in 2 separate and in 1 multivariable models.
Both hs-CRP and the WBC count may independently of each other predict early outcomes in STEMI patients treated with primary PCI, which suggests different pathological significance of these 2 non-specific inflammatory markers in STEMI.
在接受直接经皮冠状动脉介入治疗(PCI)的ST段抬高型心肌梗死(STEMI)患者中,炎症标志物与死亡率之间的关联仍存在争议。因此,在本研究中,我们评估了接受直接PCI治疗的STEMI患者中,高敏C反应蛋白(hs-CRP)、白细胞(WBC)总数、中性粒细胞(N)和淋巴细胞(L)计数以及N/L比值与院内死亡率发生之间的关系。
对1078例因直接PCI入院的连续、未经选择的STEMI患者入院时进行炎症参数评估。6.3%的患者发生院内死亡。在单因素分析中,炎症参数中只有hs-CRP(p<0.001)、WBC计数(p=0.004)和N计数(p=0.020)是死亡的预测因素。在对其他基线临床变量进行调整后,hs-CRP和WBC计数在两个单独的多变量模型以及一个综合多变量模型中进行分析时,均与死亡率保持独立关联。
hs-CRP和WBC计数可能相互独立地预测接受直接PCI治疗的STEMI患者的早期预后,这表明这两种非特异性炎症标志物在STEMI中具有不同的病理意义。